Join
Live feed
·
INSIDERFilingvia Quantisnow
Contineum Therapeutics Inc. logo

Chief Scientific Officer Lorrain Daniel S. exercised 33,009 shares at a strike of $1.01 and sold $594,578 worth of shares (37,179 units at $15.99) as part of a pre-agreed trading plan, decreasing direct ownership by 3% to 135,202 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CTNM (Contineum Therapeutics Inc.) and more on Quantisnow.